Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. Macrophages are present in the living ecosystem of many types of cancer. Using digital imaging, bioinformatics, and machine learning techniques, research led by N2CR member, Dr Anand Jeyasekharan, discovered 6 different macrophage signatures (MacroSigs) that can help distinguish types of macrophages in normal lymph nodes and diffuse large B-cell lymphoma (DLBCL), a tumour arising from our lymph nodes. This groundbreaking discovery helps doctors understand the evolution of this disease and how some DLBCL tumours relapse after chemotherapy. 

Read more: https://www.nature.com/articles/s41467-024-46220-z

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

New Hope for Gastric Cancer Patients with Peritoneal Metastasis

A breakthrough study, co-led by N2CR member A/Prof Raghav Sundar and includes Prof Jimmy So, A/Prof Yvonne Tay and Dr …

Read More →
Research News

Potential New Approach to Boost Myeloma Treatment by Blocking Key Cancer Gene

Multiple myeloma is a cancer of plasma cells, and its development and therapy resistance remain poorly understood. This study led …

Read More →
Research News

Novel Drug Induces Colorectal Cancer Cell Death by Inhibiting Wnt Signaling

This study co-led by N2CR member A/Prof Gautam Sethi, investigates the effects of CHL-C (an imidazopyridine-tethered chalcone) on colorectal cancer …

Read More →